StressMarq Biosciences is a bioreagents company producing antibodies, proteins, assay kits and small molecules for the life sciences research market. Our customers include scientists in academia, biotech/CROs/pharma and government institutions. In recent years, StressMarq has developed a range of fibrilized and oligomeric protein preparations for use in neurodegenerative disease research, including alpha synuclein, amyloid beta, tau, SOD1 and TTR. Our strategic efforts are currently focused on being a world leader in the development and supply of fibrilized proteins, oligomers, and antibodies to these constructs to assist researchers studying Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. Additionally, our diverse portfolio of antibodies, proteins, immunoassay kits and small molecules bridge across the life sciences, including products for neuroscience, cancer research, cardiovascular disease and cell signaling. To aid research worldwide, StressMarq has an extensive network of international distributors in over 45 countries.